Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

Satsuma Pharmaceuticals Announces the Appointment of Thomas M. Soloway to its Board of Directors

Stock Market Quotes and News

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced that it has appointed biopharmaceutical industry veteran Thomas M. Soloway to its Board of Directors...

Mentions: Nasdaq Satsuma Pharmaceuticals, Inc. Thomas M. Soloway